P. Deny et al., POLYMERASE-CHAIN-REACTION-BASED SEMI-QUANTIFICATION OF HEPATITIS-D VIREMIA IN PATIENTS TREATED WITH HIGH-DOSES OF ALPHA-2B INTERFERON, Research in virology, 145(5), 1994, pp. 287-295
To study the antiviral efficacy of high doses of alpha 2b interferon (
alpha 2b-IFN) for chronic hepatitis D treatment, we used polymerase-ch
ain-reaction(PCR)-based semi-quantitative detection of HDV RNA. The se
miquantification method used was based on the appearance of a positive
amplification signal as a function of the number of PCR cycles. By am
plifying dilutions (10(-1)-10(-8)) of an HDV-positive woodchuck liver
RNA, we confirmed that exponential amplification efficacy occurred at
between 20 and 30 cycles. Positive signals were observed from dilution
10(-2) (gel electrophoresis after 20 cycles of PCR) to dilution 10(-7
) (hybridization after 30 cycles of PCR). To characterize the HDV RNA
level in sera of 8 patients treated with alpha 2b-IFN (10 MU/3 times a
week) for 1 year, we extracted RNA from serum samples taken every 6 m
onths. All samples were amplified in parallel for 20 and 30 PCR cycles
. Analysis of HDV cDNA after ethidium bromide/agarose gel electrophore
sis and after molecular hybridization (100 times more sensitive than g
el analysis), enabled us to grade the signals; observed from negative
to positive as 1 +, 2 +, 3 + and 4 +, with all results being positive.
Three types of evolution of HDV viraemia were evidenced among the 8 t
reated patients. HDV replication continued to occur at a high level at
the 6th and 12th month in 2 patient sera. For 2 other patients, an HD
V RNA decrease or disappearance was evidenced in the serum at the 6th
month; however, viral replication recurred at a higher level at the 12
th month. Finally; the HDV genome was no longer detected during therap
y in the final 4 patients. These results were compared to clinical and
biological data. The level of alanine aminotransferase (ALAT) paralle
led HDV RNA gradation in 15 samples from 5 patients. However, in 2 pat
ients, HDV-RNA was negative at the 6th month, before the normalization
of ALAT. In the serum of another patient, HDV RNA was still detected
when the ALAT level was normal. This study shows the usefulness of HDV
PCR in appreciating the potential benefits of alpha 2b-IFN during chr
onic hepatitis D infection. However, long-term improvement was present
in only one patient in whom a negative HDV PCR result was associated
with loss of HBs-Ag. This simple approach uses complementary results o
f only two PCR experiments and quickly provides information on the lev
el of HDV viraemia.